This brand name is authorized in South Africa
The drug VENTEZE contains one active pharmaceutical ingredient (API):
|
1
Salbutamol
UNII 021SEF3731 - ALBUTEROL SULFATE
|
|
Salbutamol is a selective β2-agonist providing short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. At therapeutic doses it acts on the β2-adrenoceptors of bronchial muscle. Salbutamol is administered for the symptomatic relief of bronchospasm associated with chronic or acute asthma, bronchitis or other obstructive pulmonary diseases. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| R03CC02 | Salbutamol | R Respiratory system → R03 Drugs for obstructive airway diseases → R03C Adrenergics for systemic use → R03CC Selective beta-2-adrenoreceptor agonists |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 30/10.2.1/0180, 34/10.2.1/0076, 37/10.2.1/0351, A39/10.2.1/0154, M/10.2/111, M/10.2/14, M/10.2/15, R/10.2.1/292, T/10.2/84, U/10.2.1/187 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
